Jul 1 at 06:25 AM
$Hims & Hers Health(HIMS.US) | Canaccord maintains ๐๐ฎ๐ฒ on ๐๐ข๐ฆ๐ฌ & ๐๐๐ซ๐ฌ, ๐ซ๐๐ข๐ฌ๐๐ฌ ๐๐ ๐ญ๐จ $๐๐ ๐๐ซ๐จ๐ฆ $๐๐
Analyst highlights a solid start to branded weight loss drugs, constructive sales data, and sees Hims as one of Novo's most "voluminous" partners.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
